<DOC>
	<DOCNO>NCT02466373</DOCNO>
	<brief_summary>This study develop assess pharmacodynamic pharmacokinetic property intravenous ( IV ) clonidine critically ill patient ICU , estimate optimal dose strategy IV clonidine .</brief_summary>
	<brief_title>Pharmacokinetics Clinical Effects Escalating Doses Clonidine ICU Patients</brief_title>
	<detailed_description>Many patient intensive care unit ( ICU 's ) require sedation analgesia tolerate mechanical ventilation ICU procedure . Commonly use GABA-ergic anaesthetic like propofol , midazolam morphine potential adverse effect may increase morbidity , prolong ICU stay provoke delirium . Recent study show sedation alpha-2-adrenergic agonist may lead reduction total amount gamma-aminobutyric acid ( GABA ) -ergic anaesthetic reduction delirium1In clinical practice alpha-2-adrenergic agent clonidine widely use label add-on sedative mechanically ventilated patient suffer delirium , large study prove therapy effective safe . Limited information exist pharmacokinetics iv clonidine , especially ICU patient . Besides , dose regimen clonidine differ widely among ICU 's Netherlands , literature . The sample size require pharmacokinetic modelling acceptable level precision inversely related number blood sampling take individual . Population pharmacokinetic experiment publish generally use 50 subject . However , investigator study relatively large number blood sample take ( &gt; 10 per subject protocol complete , see section 6.3 ) . THe investigator estimate sufficient precision obtain sample size 24 subject , generate estimate 240 360 blood sample . In recent publication computer simulate population pharmacokinetics absorption model use design involve 6 sampling per subject , estimate two-compartment first-order model would need 50 subject ( i.e . 300 blood sampling ) obtain model 50 % precision power 0.8 . The investigator 24 subject treat 3 different dos clonidine ( 600 , 1200 1800 Âµg/day ) , 8 per treatment arm . On top , 8 patient receive clonidine serve reference group , order interpret hemodynamic safety data , illustrate dose-response relationship .</detailed_description>
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<criteria>In order eligible participate study , subject must : least 18 year age intubate sedated start study . Because high incidence delirium ICU age category , age group &gt; 18 year include Severe neurotrauma , Severe dementia ( live nursing home ) Inability speak Dutch English , one cause able use CAMICU . The use clonidine 96 hour start study . Bradycardia ( &lt; 50/min ) Severe hypotension ( MAP &lt; 65 volume resuscitation vasopressor ) Pregnancy lactation ( pregnancy test routinely perform premenopausal woman ICU ) . Epilepsy Known clonidine intolerance Liver cirrhosis ( Child Pugh class C ) Recent acute myocardial infarction Severe heart failure ( LVEF &lt; 30 % ) Second third degree atrioventricular ( AV ) block without permanent pacemaker Expected transfer another hospital .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>clonidine</keyword>
	<keyword>pharmacodynamics</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>intensive care</keyword>
	<keyword>delirium</keyword>
</DOC>